We envisage that ERG fusion-positive prostate cancer cells are susceptible to energy stress and the PGC1α-Sirt1 axis might provide survival benefits to tumors by activating antioxidant and metabolic functions of ERG fusion. This evidence concerns the gene PPARGC1A and prostate cancer.